442 related articles for article (PubMed ID: 33283171)
1. A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.
Da Vià MC; Ziccheddu B; Maeda A; Bagnoli F; Perrone G; Bolli N
Hemasphere; 2020 Dec; 4(6):e502. PubMed ID: 33283171
[TBL] [Abstract][Full Text] [Related]
2. Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation.
Gong L; Qiu L; Hao M
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339250
[TBL] [Abstract][Full Text] [Related]
3. The molecular pathogenesis of multiple myeloma.
Bolli N; Martinelli G; Cerchione C
Hematol Rep; 2020 Dec; 12(3):9054. PubMed ID: 33408844
[TBL] [Abstract][Full Text] [Related]
4. Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
Lionetti M; Da Vià MC; Albano F; Neri A; Bolli N; Musto P
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282760
[TBL] [Abstract][Full Text] [Related]
5. Multiple Myeloma Genomics - A Concise Review.
Castaneda O; Baz R
Acta Med Acad; 2019 Apr; 48(1):57-67. PubMed ID: 31264433
[TBL] [Abstract][Full Text] [Related]
6. A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration.
Schürch CM; Rasche L; Frauenfeld L; Weinhold N; Fend F
Virchows Arch; 2020 Mar; 476(3):337-351. PubMed ID: 31848687
[TBL] [Abstract][Full Text] [Related]
7. Molecular and immunological mechanisms of clonal evolution in multiple myeloma.
Forster S; Radpour R; Ochsenbein AF
Front Immunol; 2023; 14():1243997. PubMed ID: 37744361
[TBL] [Abstract][Full Text] [Related]
8. Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma.
Bianchi G; Ghobrial IM
Curr Cancer Ther Rev; 2014; 10(2):70-79. PubMed ID: 25705146
[TBL] [Abstract][Full Text] [Related]
9. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
Heider M; Nickel K; Högner M; Bassermann F
Oncol Res Treat; 2021; 44(12):672-681. PubMed ID: 34749378
[TBL] [Abstract][Full Text] [Related]
10. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.
Dutta AK; Alberge JB; Sklavenitis-Pistofidis R; Lightbody ED; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2022 Apr; 19(4):223-236. PubMed ID: 35017721
[TBL] [Abstract][Full Text] [Related]
11. Genomic complexity of multiple myeloma and its clinical implications.
Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
[TBL] [Abstract][Full Text] [Related]
12. Towards Stratified Medicine in Plasma Cell Myeloma.
Egan P; Drain S; Conway C; Bjourson AJ; Alexander HD
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775669
[TBL] [Abstract][Full Text] [Related]
13. Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.
Salomon-Perzyński A; Jamroziak K; Głodkowska-Mrówka E
Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573876
[TBL] [Abstract][Full Text] [Related]
14. Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma.
Barwick BG; Gupta VA; Vertino PM; Boise LH
Front Immunol; 2019; 10():1121. PubMed ID: 31231360
[TBL] [Abstract][Full Text] [Related]
15. Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming.
Liang Y; He H; Wang W; Wang H; Mo S; Fu R; Liu X; Song Q; Xia Z; Wang L
Mol Cancer; 2022 Sep; 21(1):182. PubMed ID: 36131282
[TBL] [Abstract][Full Text] [Related]
16. Smoldering multiple myeloma: pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategies.
Kazandjian D; Mailankody S; Korde N; Landgren O
Clin Adv Hematol Oncol; 2014 Sep; 12(9):578-87. PubMed ID: 25654479
[TBL] [Abstract][Full Text] [Related]
17. The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease.
Bishop RT; Miller AK; Froid M; Nerlakanti N; Li T; Frieling JS; Nasr MM; Nyman KJ; Sudalagunta PR; Canevarolo RR; Silva AS; Shain KH; Lynch CC; Basanta D
Nat Commun; 2024 Mar; 15(1):2458. PubMed ID: 38503736
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
Chan FC; Lim E; Kridel R; Steidl C
J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
[TBL] [Abstract][Full Text] [Related]
19. Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A Review.
Maura F; Bolli N; Rustad EH; Hultcrantz M; Munshi N; Landgren O
JAMA Oncol; 2020 Mar; 6(3):425-432. PubMed ID: 31830214
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary biology of high-risk multiple myeloma.
Pawlyn C; Morgan GJ
Nat Rev Cancer; 2017 Aug; 17(9):543-556. PubMed ID: 28835722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
